Clinical Trial

IMPACT OF CARDIAC AUTONOMIC NEUROPATHY ON QT AND QTC INTERVAL

Study acronym: QT interval
Completed
View on ClinicalTrials.gov →
Summary
This prospective observational cohort study evaluated the effect of cardiac autonomic neuropathy (CAN) on perioperative ventricular repolarization, specifically QT and corrected QT (QTc) intervals, in patients undergoing elective coronary artery bypass grafting (CABG) surgery under general anesthesia. The study was conducted in a tertiary care university hospital between October 2023 and December 2024. Adult patients scheduled for isolated elective CABG surgery with sinus rhythm on preoperative electrocardiography were screened for eligibility. Cardiac autonomic function was assessed preoperatively using standardized Ewing's cardiovascular reflex tests. Patients were classified into two groups according to test results: CAN-positive (≥2 abnormal tests) and CAN-negative (\<2 abnormal tests). QT and QTc intervals were measured at predefined perioperative time points, including before anesthesia induction, baseline, before intubation, at 1 and 30 minutes after intubation, before cannulation, and 24 hours postoperatively. The primary objective was to compare perioperative QT and QTc interval changes between patients with and without CAN. Secondary outcomes included QT and QTc variability (ΔQT, ΔQTc) and the incidence of clinically significant QTc prolongation.
Trial Details
NCT Number NCT07684768
Lead Sponsor Haseki Training and Research Hospital
Conditions Coronary Artery Disease, Cardiac Autonomic Neuropathy, QT Interval Prolongation
Enrollment 60 participants
Start Date 2023-10-05
Primary Completion 2024-12-20 (estimated)
Study Completion 2024-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-06